Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹-326 Cr₹91 Cr₹18 Cr₹-186 Cr₹376 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹-326 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹-326 Cr
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹-326 Cr
Negative
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,577.3 Cr -0.5% 7.6% -15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.5%

7.6%

-15.1%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses